The research investigated the association of the Neutrophil Percentage-to-Albumin Ratio (NPAR) with mortality risk in diabetes or prediabetes patients. NPAR is a metric that reflects both inflammation, as presented in neutrophils, and nutrition, as presented in albumin. The researchers had 6,080 American adults with diabetes or prediabetes data, obtained between 2001 and 2018, via the National Health and Nutrition Examination Survey (NHANES). The population was followed up for a total of 53,217 person-years over which 1,378 deaths occurred, 476 from cardiovascular disease.
The research investigated the association of the Neutrophil Percentage-to-Albumin Ratio (NPAR) with mortality risk in diabetes or prediabetes patients. NPAR is a metric that reflects both inflammation, as presented in neutrophils, and nutrition, as presented in albumin. The researchers had 6,080 American adults with diabetes or prediabetes data, obtained between 2001 and 2018, via the National Health and Nutrition Examination Survey (NHANES). The population was followed up for a total of 53,217 person-years over which 1,378 deaths occurred, 476 from cardiovascular disease.
This case report describes a rare and extremely malignant tumor named Primary Cardiac Lymphoma (PCL), which occurs in the heart. Because of the rarity of cardiac cancer, its diagnosis generally presents major challenges. The report describes the case of a 67-year-old male patient who initially came in for medical assessment after experiencing recurrent attacks of syncope.
The FDA has provided traditional approval to pembrolizumab (Keytruda) plus trastuzumab, fluoropyrimidine-, and platinum-based chemotherapy for the initiation of treatment in adult patients with HER2-positive gastric or GEJ adenocarcinoma with PD-L1 expression (CPS ≥ 1). It was previously approved in May 2021, under accelerated approval, on the basis of interim results from the KEYNOTE-811 trial.
US pharma giant Eli Lilly has launched its highly anticipated diabetes and obesity drug, Mounjaro (tirzepatide), in India. The drug, available in 2.5 mg and 5 mg single-dose vials, is priced at ₹3,500 and ₹4,375, respectively. Since it is taken once a week, the monthly cost ranges from ₹14,000 to ₹17,500, significantly lower than the $1,000–$1,200 (₹86,000–1 lakh) price in the US.
